O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+5.97%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$8.28B
AUM Growth
+$8.28B
(+5.4%)
Cap. Flow
+$285M
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
35.4%
Holding
137
New
11
Increased
41
Reduced
26
Closed
12
Top Buys
| 1 |
Ironwood Pharmaceuticals
IRWD
|
$120M |
| 2 |
CELG
Celgene Corp
CELG
|
$110M |
| 3 |
SHPG
Shire pic
SHPG
|
$74.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
$73.6M |
| 5 |
TRNX
TORNIER N V SHARES (NLD)
TRNX
|
$60.8M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$156M |
| 2 |
AGN
ALLERGAN INC
AGN
|
$123M |
| 3 |
Prothena Corp
PRTA
|
$72.4M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$60M |
| 5 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$57.6M |
Sector Composition
| 1 | Healthcare | 84.96% |
| 2 | Financials | 0.08% |
| 3 | Technology | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Exact Sciences
EXAS
$8.98B
| $29.3M | 0.34% | 1,723,000 -170,000 | -9% | -$2.9M |
|
|
ARRY
52
DELISTED
Array Biopharma Inc
ARRY
| $29.2M | 0.34% | 6,402,800 +105,800 | +2% | +$482K |
|
53
Medtronic
MDT
$119B
| $27M | 0.32% | 423,300 +100,300 | +31% | +$6.4M |
|
|
XNPT
54
DELISTED
XENOPORT, INC.
XNPT
| $26.8M | 0.31% | 5,546,100 | – | – |
|
55
Eli Lilly
LLY
$657B
| $24.9M | 0.29% | 400,000 -143,000 | -26% | -$8.89M |
|
|
MRTX
56
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $23.4M | 0.28% | 1,172,000 -102,332 | -8% | -$2.05M |
|
57
Alkermes
ALKS
$4.78B
| $21.8M | 0.26% | +433,300 | New | +$21.8M |
|
|
QGENF
58
DELISTED
QIAGEN NV
QGENF
| $19.1M | 0.22% | +781,400 | New | +$19.1M |
|
59
Cardinal Health
CAH
$35.5B
| $19M | 0.22% | 277,000 +10,000 | +4% | +$686K |
|
|
NPSP
60
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $18.2M | 0.21% | +550,200 | New | +$18.2M |
|
61
Cerus
CERS
$251M
| $17.6M | 0.21% | 4,238,000 | – | – |
|
62
Bausch Health
BHC
$2.74B
| $17.4M | 0.2% | 138,000 +5,000 | +4% | +$631K |
|
63
Jazz Pharmaceuticals
JAZZ
$7.75B
| $16.9M | 0.2% | 115,000 | – | – |
|
|
FPRX
64
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $16.7M | 0.2% | 1,075,400 | – | – |
|
|
COV
65
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $16.3M | 0.19% | +180,600 | New | +$16.3M |
|
66
Puma Biotechnology
PBYI
$254M
| $14.4M | 0.17% | +218,100 | New | +$14.4M |
|
67
MEI Pharma
MEIP
$160M
| $12.2M | 0.14% | 1,924,500 | – | – |
|
|
GEVA
68
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $11.6M | 0.14% | 111,100 | – | – |
|
|
QCOR
69
DELISTED
QUESTCOR PHARMA INC
QCOR
| $11.6M | 0.14% | 125,000 +45,000 | +56% | +$4.16M |
|
|
AGEN
70
Agenus
AGEN
$133M
| $11.5M | 0.14% | 3,586,100 -1,463,900 | -29% | -$4.71M |
|
|
NXTM
71
DELISTED
NxStage Medical Inc.
NXTM
| $11.4M | 0.13% | 795,200 -1,317,800 | -62% | -$18.9M |
|
|
NUVA
72
DELISTED
NuVasive, Inc.
NUVA
| $11.2M | 0.13% | 316,000 | – | – |
|
73
Xoma
XOMA
$392M
| $11.2M | 0.13% | 2,437,000 | – | – |
|
74
Insmed
INSM
$28.8B
| $10.8M | 0.13% | +538,500 | New | +$10.8M |
|
|
RDHL
75
Redhill Biopharma
RDHL
$3.1M
| $10.6M | 0.12% | 605,800 -25,780 | -4% | -$451K |
|